Iantrek founder, Dr. Ianchulev unveils T-Rex technology at G360

At the annual 2023 Glaucoma Research Foundation meeting, Dr, Ianchulev, Iantrek’s founder and Professor of Ophthalmology at New York Eye and Ear of Mount Sinai, gave the New Horizons Innovation Symposium presentation, where he unveiled the company’s new canal micro-interventional technology, T-Rex. He also discussed the recently published clinical results on the CycloPen micro-interventional system, as well as the advantages of biostenting using biotissue and 100% hardware-free implantation approaches.